We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene in Human Egg Essential for Fertility

By Biotechdaily staff writers
Posted on 24 May 2002
A gene in the human egg that appears to be essential for fertility has been discovered by fertility researchers. More...
The finding was reported in the April 2002 issue of Human Reproduction.

The gene may also play a role in premature ovarian failure, a condition in which the ovaries stop functioning for years or decades before natural menopause. Thus the gene may be associated with unexplained infertility in women. The discovery builds on prior research conducted in mice, where researchers found a gene in female mice that they named "Mater,” short for "maternal effect” gene.

The Mater gene produces a protein essential to the development of a fertilized egg. In the current study, a gene was identified in women that appears to be the human counterpart.

While investigating premature ovarian failure, the researchers found that in some cases, the ovaries of healthy women appeared to be attacked and destroyed by their immune systems. Mice with a similar disorder also experience such an attack. The target of the attack is a protein produced by the mouse Mater gene. To investigate this protein's function, the researchers developed a strain of mice that lacked both copies of the gene and found that all the females were infertile. They also found that the DNA of human and mouse Mater genes are 67% identical. The proteins produced by mouse and human Mater genes are 53% identical. Thus, the Mater mutation or its protein deficiency may cause infertility in some women.

”If the human gene is found to serve the same function as the mouse gene, it may result in a new approach to the study and treatment of fertility,” said Lawrence Nelson, M.D., senior author of the study and a member of the developmental endocrinology branch of the US National Institute of Child Health and Human Development (NICHD), which conducted the study.

One avenue of research suggested by the study is to examine women who have a history of successful fertilization but whose embryos fail to develop, to see if they have mutations on the Mater gene. If they do, researchers may one day be able to induce pregnancy by injecting Mater protein into the egg cells of such women before conception.





Related Links:
National Institute of Child Health and Human Development

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.